Novel immunotherapeutics have transformed oncology, moving away from broad, non-specific treatments toward highly ...
APPLETON, WI - March 17, 2026 - PRESSADVANTAGE - McCormick Industries, a precision machining company serving diverse ...
The biotech industry needs to stop waiting for a rebound. The pandemic changed everything, though not in the ways most people ...
Topline data from Phase 3 OnPrime/GOG-3076 ovarian cancer registrational trial of Olvi-Vec expected in 2H26 ---- Interim systemic lung cancer ...
6d
Nestle worker wins Rs 27 lakh after being sacked for vaping in toilet, had caused factory shutdown
Luke Billings, who had been employed as a technical operator at the company’s Tutbury site in Staffordshire since 2012, lost ...
ICOTYDE is the first and only IL-23R targeted oral peptide that delivers complete skin clearance and a favorable safety ...
Softcat (LON:SCT) reported what management described as an “exceptional” first-half performance for FY26, delivering strong ...
In Gaza, we watch people being starved by Israel. In rich countries, we watch people starving themselves. The situations are ...
Chief manufacturing officers must treat slow tech transfer and CDMO onboarding as a strategic liability, given patent cliffs, ...
Additional data analyses from Orbit and Cosmic Phase 3 studies of setrusumab (UX143) in osteogenesis imperfecta ongoingCash of $41.0 million as ...
Sanofi's venglustat earns Breakthrough Therapy designation in the US for type 3 Gaucher disease Paris, March 18, 2026. The US Food and Drug Administration (FDA) has granted Breakthrough Therapy design ...
Additional data analyses from Orbit and Cosmic Phase 3 studies of setrusumab (UX143) in osteogenesis imperfecta ongoing Cash of $41.0 million as of December 31, 2025, expected to provide runway into ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results